EMA – Page 18 – Pharma.Tips

Change impact not assessed during change control – regulatory deficiency risk

Navigating Regulatory Risks: Assessing Change Impact During Change Control The pharmaceutical industry faces continuous scrutiny from regulatory bodies, emphasizing the importance of change control processes. A significant risk arises when…

CSV compliance weak during inspection readiness – risk-based validation alignment

Enhancing CSV Compliance for Inspection Readiness in Pharmaceutical Manufacturing In the pharmaceutical sector, the robust execution of Computerized System Validation (CSV) is crucial, particularly during inspection periods. A weak CSV…

Validation gaps identified during lifecycle management – risk-based validation alignment

Addressing Validation Gaps in Lifecycle Management for Regulatory Compliance In today’s complex pharmaceutical manufacturing landscape, identifying validation gaps during lifecycle management is crucial for maintaining regulatory compliance. Such gaps can…

Validation gaps identified during site expansion – risk-based validation alignment

Addressing Validation Gaps During Site Expansion: A Comprehensive Playbook In the dynamic environment of pharmaceutical manufacturing, site expansions can pose significant challenges, particularly when it comes to maintaining compliance with…

Validation gaps identified during site expansion – CAPA and revalidation strategy

Addressing Validation Gaps Encountered During Site Expansion: A Hands-On CAPA and Revalidation Guide Validation gaps often emerge during a site expansion project, potentially jeopardizing compliance and product quality. For pharmaceutical…

Validation gaps identified during change control – risk-based validation alignment

Mitigating Validation Gaps Found During Change Control: A Comprehensive Playbook Validation gaps identified during change control can lead to significant compliance and quality issues in pharmaceutical manufacturing. They often result…

CSV compliance weak during lifecycle management – risk-based validation alignment

Enhancing CSV Compliance Throughout Lifecycle Management for Regulatory Readiness Pharmaceutical manufacturing often grapples with the challenge of maintaining compliance in computer system validation (CSV) during the lifecycle of software and…

Incomplete validation lifecycle during inspection readiness – risk-based validation alignment

Mitigating Risks of Incomplete Validation Lifecycles for Inspection Readiness In the pharmaceutical manufacturing landscape, maintaining compliant operational standards is critical. One pressing issue is managing the risks associated with an…

Requalification overdue during inspection readiness – risk-based validation alignment

Strategic Playbook for Managing Requalification Overdue During Inspection Readiness In the dynamic environment of pharmaceutical manufacturing, inspection readiness is paramount. A critical issue many companies face is having overdue requalifications…

Incomplete validation lifecycle during system upgrades – preventing repeat validation findings

Preventing Repeat Findings from Incomplete Validation during System Upgrades Incomplete validation of systems during upgrades is a chronic issue faced by many pharmaceutical manufacturers. Such lapses can lead to regulatory…

Incomplete validation lifecycle during inspection readiness – inspection evidence expectations

Understanding and Addressing Incomplete Validation Lifecycle in Inspection Readiness Incomplete validation during the manufacturing lifecycle poses significant risks during inspections, potentially leading to regulatory non-compliance. Pharmaceutical manufacturing professionals—encompassing roles in…

Requalification overdue during change control – preventing repeat validation findings

“`html Managing Requalification Delays during Change Control to Avoid Validation Findings The pharmaceutical industry operates under stringent regulatory frameworks where validation and requalification are critical for compliance. One common issue…